Crystal Structure of Diethyl[(4chlorophenyl)(dibenzylamino)methyl]propanedioate

doi:10.1007/S10870-010-9742-6

Paper

Crystal Structure of Diethyl[(4chlorophenyl)(dibenzylamino)methyl]propanedioate

Published Feb 25, 2010 · I. Meskini, L. Toupet, M. Akkurt

Journal of Chemical Crystallography

Q4 SJR score

1

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

The titled new functionalized N,O,O-ligand of type diethyl[(4-chlorophenyl)(dibenzylamino)methyl]propanedioate (4) is prepared in good yield through condensation of dibenzylamine, with 2-arylidene-malonic acid diethyl esters 3. The structure of 4 was determined by spectral (IR, 1H NMR), elemental analyses and X-ray diffraction data. The molecular conformation shows two possible pockets ready to coordinate two metal atoms.Graphical AbstractThe structure of compound was determined by spectral (IR, 1H NMR), elemental analyses and X-ray diffraction data. The molecular conformation shows two possible pockets ready to coordinate two metal atoms.

Study Snapshot

Diethyl[(4-chlorophenyl)(dibenzylamino)methyl]propanedioate (4) shows two potential metal coordination pockets, indicating its potential use as a functionalized N,O,O-ligand.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Paper

Crystal Structure of Diethyl[(4chlorophenyl)(dibenzylamino)methyl]propanedioate

References

Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.

Novel dihydroquinoline-3-carboxylic acids show potential as HIV-1 integrase inhibitors, with no significant cytotoxicity in cancer cell lines.

Design, synthesis, molecular modeling, and anti-HIV-1 integrase activity of a series of photoactivatable diketo acid-containing inhibitors as affinity probes.

Photoactivatable diketo acid-containing inhibitors (DKAs) are useful for identifying HIV-1 integrase binding sites and aiding in the understanding of HIV-1 inhibitors' HIV-1 binding interactions.

Tricyclic HIV integrase inhibitors: VI. SAR studies of 'benzyl flipped' C3-substituted pyrroloquinolines.

C3 halobenzyl-substituted tricyclic HIV integrase inhibitors show improved cell-based inhibitor potency and good balance in animal PK studies.

Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase inhibitors.

Substituted analogs of 3-acetyl-4-hydroxy-2-pyranones and their difluoridoborate complexes show potential as novel HIV-1 integrase inhibitors, with compound 9 showing the most activity.

Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors.

The 3-benzyloxyphenyl-substituted isoxazole carboxylic acid shows the best HIV-1 integrase inhibitory and antiviral activities, with N-hydroxylamidation enhancing in vitro and in vivo potency.

Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.

The phenyl substituent and linker orientation of dimeric aryldiketo-containing HIV-1 integrase inhibitors significantly impact their inhibitory potency, with hydrophobic substitutions at the 3-position and 4-amino-piperidine linkers being optimal.

Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.

This study presents a new class of substituted 2-pyrrolinone HIV-1 integrase inhibitors, enhancing their inhibitory activity and potential for future antiretroviral therapy.

Diethyl 2-((morpholin-4-yl)(phenyl)methyl)malonate

Diethyl 2-((morpholin-4-yl)(phenyl)methyl)malonate shows potential as a metal coordination compound due to its stable crystal structure and morpholine unit in an almost ideal chair conformation.

Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.

New phenanthrene diketo acid analogs show high potency as HIV integrase inhibitors, with selectivity against integrase strand transfer and potential for clinical development.

Citations

Random and Rational Approaches to HIV Drug Discovery in Africa

African scientists have made significant progress in HIV drug discovery and development, identifying inhibitors from natural sources and synthetic means, but face challenges in overcoming new challenges and advancing treatment strategies.